Navigation Links
AstraZeneca Donates $1 Million for Christiana Care Health System's Wilmington Hospital Project
Date:5/21/2010

WILMINGTON, Del., May 21 /PRNewswire-USNewswire/ -- AstraZeneca (NYSE: AZN) contributed $1 million to Wilmington Hospital today to support the expansion and renovation of the hospital as a vital part of the Christiana Care Health System.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100521/DC09042LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090407/DC95299LOGO)

The donation will go toward a $210 million investment that will help the hospital continue its mission of building a healthy community for the city of Wilmington and surrounding region. The transformational project will dramatically increase the hospital's capacity and ultimately add nearly 600 jobs.

"We are strongly committed to working with partners whose mission and interests align with our commitment to strengthening and improving the health of patients," said Rich Fante, President AstraZeneca US & Regional VP North America. "Wilmington Hospital is an outstanding facility and a critical health resource in our community. AstraZeneca takes pride in helping it grow."

"For more than a century, Christiana Care and our Wilmington facility have built a tradition of caring for our neighbors when they are ill and helping them maintain their health when they are well," said Dr. Robert Laskowski, Christiana Care Health System President and CEO. "With this gift, Wilmington is set to become a modern, leading-edge hospital offering a full range of best-in-care preventive and wellness services. Together we can ensure Delawareans receive the highest level of care and comfort across the broad spectrum of diverse medical needs for decades to come."

Governor Jack Markell said, "This gift and the expansion of the hospital will bring jobs to the city while building on the hard work that's already being done at the hospital for its patients and the area.  It represents an investment in the city and an investment in the health and welfare of its citizens."

"Our local leaders seized the chance to work together for accessible patient-focused care," said Senator Tom Carper. "The tens of thousands of people who rely on Wilmington Hospital for everything from emergency medicine to joint replacement will benefit greatly from their commitment to better care in a better place to be cared for."

"I commend AstraZeneca for this tremendous act of generosity for our community, and I applaud Christiana Care's commitment to provide the highest level of care for patients in Delaware," said Rep. Mike Castle. "The expansion of Wilmington Hospital will reduce waiting times in the emergency department, provide better access to primary care and improve health outcomes for thousands of patients."

The renovation marks the second largest project in the Christiana Care Health System's history and will create over 2,000 construction jobs. Serving as Christiana Care's anchor since 1888, the Wilmington Hospital Campus will grow by 337,000 square-feet, creating a one million square-foot, state-of-the-art medical center. When completed in 2012, the expansion will include:

  • An upgraded emergency department that will be twice its current size
  • A new surgical suite, including 13 operating rooms and four procedure rooms
  • Capacity for 120 private patient rooms
  • A new intensive care unit
  • An upgraded, 30 bed unit for the Center for Advanced Joint Replacement
  • A nine story, 286,000 square-foot tower
  • A 51,000 square-foot, state-of-the-art medical office building, allowing more physicians to practice on-site
  • A new main lobby entry repositioned on Jefferson Street with enclosed walkway to parking
  • A tranquil atrium and healing garden

The hospital expansion, which began in 2009, demonstrates Christiana Care's commitment to serving the residents of Wilmington and the surrounding area through a full range of wellness and health services to people of all ages, including women's health care services, surgery, orthopaedics, podiatry, ophthalmology, dentistry and oral surgery, pediatric medicine and general dentistry as well as diagnostic testing, an on-site pharmacy and patient education programs.

For more information visit www.christianacare.org and www.astrazeneca-us.com.


'/>"/>
SOURCE Christiana Care Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
2. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
3. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
4. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
5. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
8. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
9. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
10. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
11. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... PureLife Dental is pleased ... separator supplier for CDA members. As part of the amalgam separator endorsement, all CDA ... saving more than $400 off the retail value. This partnership between PureLife and CDA ...
(Date:6/23/2017)... ... 2017 , ... Ulster University, Magee Campus in Northern Ireland is hosting The ... to present to graduate students exciting new and innovative hope research based on iFred’s ... The Health Improvement Service of the Western Health & Social Care Trust (WHSCT) in ...
(Date:6/23/2017)... ... June 23, 2017 , ... All-Star Insurance, a family managed agency that offers ... Texas, is announcing the launch of a new charity drive to benefit women in ... United States reveal that an estimated 252, 710 new cases of invasive or high ...
(Date:6/22/2017)... ... ... Branches, Inc. has been partnering with The Miami Foundation for over 9 ... focused on providing opportunity to low-income families and breaking the cycle of generational poverty. ... to support its , Climb to College & Career initiative which focuses on postsecondary ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited ... about their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, ... silicone rings designed just for you. , From the rock face to the auto ...
Breaking Medicine News(10 mins):